SAN DIEGO, Feb. 2, 2005 (PRIMEZONE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its fourth quarter and year ended December 31, 2004, at 5:00 a.m. Pacific Time on Thursday, February 17, 2005.
Alan D. Gold, president and chief executive officer, and John F. Wilson II, chief financial officer, will host an investor conference call the same day at 10:00 a.m. Pacific Time to discuss the company's financial results and operations for the year.
The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and www.companyboardroom.com, or live by calling (877) 226-4265 with call ID number 3830436. Participants who wish to participate in the live call are encouraged to pre-register by email at firstname.lastname@example.org or by calling (310) 442-9852.
The call will be archived for two weeks on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, February 17, 2005 through midnight Pacific Time on Tuesday, February 22, 2005 by calling (800) 642-1687 (domestic) or (706) 645-9291 (international) and using access code: 3830436.
In addition, the company also said it will commence providing supplemental operating and financial data beginning with its fourth quarter ended December 31, 2004. This supplemental data will be available in the Investor Relations section of the company's web site beginning on February 17, 2005.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust focused on acquiring, owning, leasing, managing and selectively developing laboratory and office space for lease to life science tenants. Tenants include biotechnology and pharmaceutical companies, scientific research institutions, government agencies, physician groups and other entities involved in the life science industry. The company targets properties located in markets with established reputations as centers for scientific research, including San Diego, San Francisco, Seattle, Maryland, Pennsylvania, New York/New Jersey and Boston. Additional information is available at www.biomedrealty.com.
CONTACTS: Maier & Company, Inc.
Gary S. Maier / Sophie Xu